WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 407215
Description: LY3000328 is a Cathepsin S inhibitor with excellent in vitro potency and selectivity against other cysteine proteases. LY3000328 is currently in clinical trials. Cathepsin S (Cat S) plays an important role in many pathological conditions, including abdominal aortic aneurysm (AAA). Inhibition of Cat S may provide a new treatment for AAA.
MedKoo Cat#: 407215
Chemical Formula: C25H29FN4O5
Exact Mass: 484.2122
Molecular Weight: 484.5284
Elemental Analysis: C, 61.97; H, 6.03; F, 3.92; N, 11.56; O, 16.51
LY3000328, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received. Larger quantities may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to firstname.lastname@example.org to inquire quote.
Synonym: LY3000328; LY-3000328; LY 3000328.
IUPAC/Chemical Name: (3R,4S)-4-(4-fluorobenzamido)-6-(4-(oxetan-3-yl)piperazin-1-yl)chroman-3-yl methylcarbamate
InChi Key: NDEBZCZEAVMSQF-GOTSBHOMSA-N
InChi Code: InChI=1S/C25H29FN4O5/c1-27-25(32)35-22-15-34-21-7-6-18(29-8-10-30(11-9-29)19-13-33-14-19)12-20(21)23(22)28-24(31)16-2-4-17(26)5-3-16/h2-7,12,19,22-23H,8-11,13-15H2,1H3,(H,27,32)(H,28,31)/t22-,23-/m0/s1
SMILES Code: O=C(O[C@H]1COC2=C(C=C(N3CCN(C4COC4)CC3)C=C2)[C@@H]1NC(C5=CC=C(F)C=C5)=O)NC
The following data is based on the product molecular weight 484.5284 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Jadhav PK, Schiffler MA, Gavardinas K, Kim EJ, Matthews DP, Staszak MA, Coffey
DS, Shaw BW, Cassidy KC, Brier RA, Zhang Y, Christie RM, Matter WF, Qing K,
Durbin JD, Wang Y, Deng GG. Discovery of Cathepsin S Inhibitor LY3000328 for the
Treatment of Abdominal Aortic Aneurysm. ACS Med Chem Lett. 2014 Aug
27;5(10):1138-42. doi: 10.1021/ml500283g. eCollection 2014 Oct 9. PubMed PMID:
25313327; PubMed Central PMCID: PMC4190634.
2: Payne CD, Deeg MA, Chan M, Tan LH, LaBell ES, Shen T, DeBrota DJ.
Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in
healthy subjects. Br J Clin Pharmacol. 2014 Dec;78(6):1334-42. doi:
10.1111/bcp.12470. PubMed PMID: 25039273; PubMed Central PMCID: PMC4256622.